A detailed history of Legato Capital Management LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Legato Capital Management LLC holds 3,077 shares of LLY stock, worth $2.32 Million. This represents 0.36% of its overall portfolio holdings.

Number of Shares
3,077
Previous 3,077 -0.0%
Holding current value
$2.32 Million
Previous $2.79 Million 2.12%
% of portfolio
0.36%
Previous 0.39%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 26, 2024

SELL
$724.87 - $909.04 $755,314 - $947,219
-1,042 Reduced 25.3%
3,077 $2.79 Million
Q3 2023

Oct 12, 2023

SELL
$434.7 - $599.3 $1.04 Million - $1.44 Million
-2,402 Reduced 36.83%
4,119 $2.21 Million
Q4 2022

Feb 01, 2023

BUY
$321.55 - $374.67 $2.1 Million - $2.44 Million
6,521 New
6,521 $2.39 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $716B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Legato Capital Management LLC Portfolio

Follow Legato Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Legato Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Legato Capital Management LLC with notifications on news.